指南与共识牙体牙髓病

牙体牙髓病随机试验优先报告条目(PRIRATE)指南:制定方案

Preferred Reporting Items for RAndomized Trials in Endodontics (PRIRATE) guidelines: a development protocol.
指南 / 共识 · Int Endod J · 2019-03-01

PRIRATE指南旨在提升牙体牙髓病领域随机试验的规划与报告质量。项目由指导委员会设计五阶段共识流程,包括成立30人Delphi组和20人面对面共识会议组,最终形成指南及解释文档并传播更新。

要点

  • PRIRATE指南针对牙体牙髓病随机临床试验的报告质量。
  • 采用五阶段共识流程,包括Delphi法和面对面共识会议。
  • 指南将配套解释文档并定期修订更新。

核心结论

  • PRIRATE指南旨在改善牙体牙髓病领域随机试验的规划与报告质量。

研究设计与样本

  • 项目负责人设计五阶段共识流程,成立八人指导委员会,并建立30人PRIRATE Delphi组和20人面对面共识会议组。

关键数值与推荐

  • Delphi组采用9点Likert量表评分,超过70%成员评分≥7的条目纳入第二稿。
  • 共识流程重复直至每个条目满足设定条件。
  • 最终指南附解释与阐述文档,由指导委员会制定并经六名成员批准(Delphi组和面对面共识会议组各三人)。

临床怎么用

  • 牙体牙髓病随机试验的规划与报告可参考PRIRATE指南。
  • 指南将通过期刊发表、学术会议和学术团体传播。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Randomized clinical trials are acknowledged as the most appropriate methodology for demonstrating the efficacy or effectiveness of one intervention as opposed to another and thus play a major role in clinical decision-making. However, it is recognized that despite the existence of various guidelines, for example, the Consolidated Standards for Reporting Trials (CONSORT) statement, the quality of manuscripts describing randomized trials is often suboptimal. The current project aims to develop and disseminate new guidelines, Preferred Reporting Items for RAndomized Trials in Endodontics (PRIRATE), to improve the planning and reporting quality of randomized trials in the field of Endodontics. The project leads (VN, PD) designed a robust process to develop the PRIRATE guidelines. At first, a steering committee of eight members, including the project leads, was formed. Thereafter, a five-stage consensus process will be followed: initial steps, pre-meeting activities, face-to-face consensus meeting, post-meeting activities and post-publication activities. The steering committee will develop the first draft of the PRIRATE guidelines by identifying relevant and important items from various sources including the CONSORT guidelines and the Clinical and Laboratory Images in Publications (CLIP) principles. This will be followed by the establishment of a PRIRATE Delphi Group (PDG) consisting of 30 members. The individual items of the first draft of the PRIRATE guidelines developed by the steering committee will be evaluated and scored on a 9-point Likert scale by the PDG members. Items with a score of seven and above by more than 70% of PDG members will be included in the second draft of the guidelines, and the Delphi process will be repeated until each item fulfils the set conditions. After obtaining consensus from the PDG, the PRIRATE guidelines will be discussed by 20 selected individuals within a PRIRATE Face-to-face Consensus Meeting Group (PFCMG) to arrive at a final consensus. The final PRIRATE guidelines will be accompanied with an explanation and elaboration document developed by the steering committee and approved by six members, three from the PDG and three from the PFCMG. The PRIRATE guidelines will be published in journals and actively disseminated to educational institutions, national and international academic societies and presented at scientific meetings. The steering committee will periodically revise and update the PRIRATE guidelines based on feedback from stakeholders.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Nagendrababu V, Duncan HF, Bjørndal L, et al. Preferred Reporting Items for RAndomized Trials in Endodontics (PRIRATE) guidelines: a development protocol. Int Endod J. 2019. PMID: 30702139. doi:10.1111/iej.13087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。